About Kee Pharma Limited
Data last updated:
Kee Pharma Limited is a public limited company based in New Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 08 May 1991, the company has been in operation for over 35 years.
Registered with ROC Delhi under CIN U24239DL1991PLC044264.
Capital: an authorised share capital of ₹11 Cr and a paid-up capital of ₹10.48 Cr. Formerly known as Kee Pharma P Limited. It is led by directors including Anil Motihar and Harinder Motihar.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: A – 8 3Rd Floor Naraina Industrial Area Phase – Ii, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.89 Cr, a growth of 3% compared to the previous year.
The company has a workforce of approximately 222 employees as per the latest available data. Its group structure includes 3 subsidiaries.
The company is associated with 1 brand - Kee Pharma. As per MCA filings, the company has open charges of ₹9.5 Cr and satisfied charges of ₹4.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website keepharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressA – 8 3Rd Floor Naraina Industrial Area Phase – Ii, New Delhi, Delhi, India – 110028
- IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Kee Pharma
Kee Pharma operates one associated brand: Kee Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Sells health supplements and products via online store. | keepharma.com |
Competitors & Alternatives of Kee Pharma
Brands and companies operating in the same space as Kee Pharma Limited include Merck, Roivant Sciences, AbbVie and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
 Merck | Pharmaceutical products are manufactured and marketed worldwide. | Kenilworth, United Kingdom, United Kingdom | 1891 |
 Roivant Sciences | Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | New York, United States, United States | 2014 |
 AbbVie | Biopharmaceutical research and drug development are conducted globally by AbbVie. | Chicago, United States, United States | 2012 |
 Lilly | Traditional pharmaceutical medicines are developed for multiple health fields. | United States | 1876 |
 Gilead | Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | Foster City, United States, United States | 1987 |
 United Therapeutics | Treatments for chronic and life-threatening diseases are developed and commercialized. | Silver Spring, United States, United States | 1998 |
 Roche | Pharmaceuticals and diagnostics kits are developed for various diseases. | Basel, Switzerland, Switzerland | 1896 |
 Ascendis Pharma | Long-acting prodrug therapies are developed for endocrine and rare diseases. | Hellerup, Denmark, Denmark | 2007 |
 MorphoSys | Therapeutic antibodies for cancer and other diseases are developed. | Planegg, Germany, Germany | 1992 |
 Vertex Pharmaceuticals | Developer of drugs for the treatment of multiple disorders | United States | 1989 |
Business Activity of Kee Pharma
The main business activity of Kee Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Kee Pharma Limited
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Kee Pharma
Kee Pharma Limited is audited by MYMR & Associates for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MYMR & Associates | Locked | Locked | Locked |
Complete auditor history for Kee Pharma Limited
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Kee Pharma Limited
Kee Pharma has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Motihar | Managing Director | 09 Nov 1992 | 33 Years 10 Months | Current |
| Harinder Motihar Also directs: Kee Healthcare Private Limited | Director | 31 Dec 2015 | 10 Years 9 Months | Current |
| Mohit S Nigam | Additional Director | 15 Dec 2025 | 0 Years 9 Months | Current |
| Natasha Goyal Also directs: Kati Patang Lifestyle Limited, Iboard India Limited, Hindustan Thermalprojects Limited and 2 more | Director | 22 Jul 2025 | 1 Years 2 Months | Current |
Financials of Kee Pharma Limited FY 2024 filings available
Kee Pharma Limited reported revenue of ₹18.89 Cr (up 3.00% YoY) for FY 2025.
Ten-year financial statements for Kee Pharma Limited
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Kee Pharma
Shareholding and ownership data for Kee Pharma Limited
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Kee Pharma Limited
Kee Pharma has 3 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Kee Healthcare Private Limited | U24100DL2012PTC232081 | Locked |
| Kee Diagnostics Private Limited | U24231DL2004PTC128343 | Locked |
| Helvetica Industries Private Limited | U24233DL1999PTC098112 | Locked |
Showing major subsidiaries. Total: 3.
Charges & Borrowings of Kee Pharma
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2004 | Indian Bank | ₹2.95 Cr | Open |
| 11 Sep 2003 | Ge Capital Services India | ₹4.5 Lakh | Open |
| 18 Oct 2002 | Nidian Bank | ₹75 Lakh | Open |
| 20 Oct 2000 | Nidian Bank | ₹1 Cr | Open |
| 26 Dec 1999 | Indian Bank | ₹8 Lakh | Open |
Total charge records: 13 View all charges
Employees and EPFO Compliance at Kee Pharma
Kee Pharma Limited has a workforce of 222 employees as of Mar 29, 2024.
Employee and EPFO history for Kee Pharma Limited
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Kee Pharma
GST registrations and filing compliance for Kee Pharma Limited
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Kee Pharma
Credit ratings, litigation, and regulatory alerts for Kee Pharma Limited
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kee Pharma
MSME payment history for Kee Pharma Limited
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kee Pharma
Corporate group structure for Kee Pharma Limited
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kee Pharma
MCA filings and documents for Kee Pharma Limited
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Kee Pharma
Frequently Asked Questions about Kee Pharma Limited
Kee Pharma is an active public limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 08 May 1991 (35+ years old) and is registered under CIN U24239DL1991PLC044264. The company has 222 employees.
Kee Pharma reported revenue of ₹18.89 Cr for FY 2025 (up 3.00% YoY).
The current directors of Kee Pharma are:
- Anil Motihar - Managing Director
- Harinder Motihar - Director
- Mohit S Nigam - Additional Director
- Natasha Goyal - Director
The primary industry of Kee Pharma is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Kee Pharma can be reached at the registered office: A – 8 3Rd Floor Naraina Industrial Area Phase – Ii, New Delhi, Delhi, India – 110028, or through the website keepharma.com.
The authorised capital is ₹11 Cr, and the paid-up capital is ₹10.48 Cr.